Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,955,170
+$251,825 QoQ
Shares Held
313,157
+33.4% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. ENTA ranks #65 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,955,170 | 313,157 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,703,345 | 234,835 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,715,332 | 226,845 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,994,590 | 396,110 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,971,239 | 357,109 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $265,068 | 46,099 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $392,218 | 37,859 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $778,264 | 60,005 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,915,465 | 109,706 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,912,713 | 203,264 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,538,957 | 137,776 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $416,358 | 19,456 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $403,025 | 9,966 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $801,400 | 17,227 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $504,124 | 9,719 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $354,052 | 7,490 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $568,941 | 7,993 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,055,370 | 14,113 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $372,616 | 6,559 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $350,583 | 7,966 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $403,141 | 8,174 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,507,053 | 35,797 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,023,338 | 44,197 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,124,367 | 62,226 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $4,009,225 | 77,955 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||